Glutamine depletion by bacterial enzyme Crisantaspase and/or GS inhibitor methionine-L-sulfoximine (MSO) hinders the tumor growth of human HCC xenografts induced by CTNNB1-mutated HCC cell lines (Chiu et al., 2014). The gene discussed is GLUL; the disease is hepatocellular carcinoma.